ConductScience.org, home

Paper22531442

Marketed therapeutic antibodies compendium.

Reichert JM. MAbs, 2012. Cited by 279 papers, by iCite.

Cite this record

ConductScience Library. Marketed therapeutic antibodies compendium. Papers, record 22531442. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22531442

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Marketed therapeutic antibodies compendium.
PubMed
Journal
MAbs
PubMed
Year
2012
PubMed
Publication types
Editorial
PubMed
Citations, by iCite
279
iCite
Relative citation ratio, by iCite
8.91
iCite
Revised in PubMed
2021-10-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Reichert JMJanice M

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
ImmunotherapyMajor topic
Animals
Drug Approval
Europe
Humans
Marketing
Product Recalls and Withdrawals
United States

Source PubMed

Download CSV of topics

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122327425Which are the antibodies to watch in 2012?MAbs2012https://conductscience.org/library/papers/22327425PubMed
220150766Antibody immunosuppressive therapy in solid-organ transplant: Part I.MAbs2010https://conductscience.org/library/papers/20150766PubMed
320177026Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.J Clin Oncol2010https://conductscience.org/library/papers/20177026PubMed
420046573Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin.MAbs2009https://conductscience.org/library/papers/20046573PubMed
512241873Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study.Lancet2002https://conductscience.org/library/papers/12241873PubMed
611645897Delaying approval of a critical drug: safety, efficacy, economics, compassion.J Med Humanit1994https://conductscience.org/library/papers/11645897PubMed
722531443The birth pangs of monoclonal antibody therapeutics: the failure and legacy of Centoxin.MAbs2012https://conductscience.org/library/papers/22531443PubMed
87323946Expression of spleen cell immunoglobulin phenotype in hybrids with myeloma cell lines.Somatic Cell Genet1981https://conductscience.org/library/papers/7323946PubMed
9714156A better cell line for making hybridomas secreting specific antibodies.Nature1978https://conductscience.org/library/papers/714156PubMed

Download CSV of references

Cited by142

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 279 citations.

PMIDTitleJournalYearIn PapersSource
42530225Lack of Differences in the Pharmacokinetics of Therapeutic Monoclonal Antibodies Between Japanese and Non-Japanese Individuals.J Clin Pharmacol2026https://conductscience.org/library/papers/42530225PubMed
42245239The landscape of antibody production systems: recombinant expression for research, diagnostics and therapy.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/42245239PubMed
41145745Spotlight on Clinical In-Use Parameters for Intravenous Infusion of Therapeutic Antibodies: A Systematic Review.Pharm Res2025https://conductscience.org/library/papers/41145745PubMed
39273189Lectin-Based Fluorescent Comparison of Glycan Profile-FDA Validation to Expedite Approval of Biosimilars.Int J Mol Sci2024https://conductscience.org/library/papers/39273189PubMed
37746528Hydrogen Deuterium Exchange and other Mass Spectrometry-based Approaches for Epitope Mapping.Front Anal Sci2023https://conductscience.org/library/papers/37746528PubMed
37508373Solute Transport across the Lymphatic Vasculature in a Soft Skin Tissue.Biology (Basel)2023https://conductscience.org/library/papers/37508373PubMed
37067466Using Cluster Theory to Calculate the Experimental Structure Factors of Antibody Solutions.Mol Pharm2023https://conductscience.org/library/papers/37067466PubMed
36998195Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics.MAbs2023https://conductscience.org/library/papers/36998195PubMed
36213257The global landscape of approved antibody therapies.Antib Ther2022https://conductscience.org/library/papers/36213257PubMed
36177046HLAII peptide presentation of infliximab increases when complexed with TNF.Front Immunol2022https://conductscience.org/library/papers/36177046PubMed
35449588Identification, Efficacy, and Stability Evaluation of Succinimide Modification With a High Abundance in the Framework Region of Golimumab.Front Chem2022https://conductscience.org/library/papers/35449588PubMed
35087799Electrical Stimulation for Immune Modulation in Cancer Treatments.Front Bioeng Biotechnol2021https://conductscience.org/library/papers/35087799PubMed
35024565Risk for Postmarket Black Box Warnings in FDA-Approved Monoclonal Antibodies.Mayo Clin Proc Innov Qual Outcomes2022https://conductscience.org/library/papers/35024565PubMed
34434981Immune Checkpoint Inhibitors Mediated Lymphocytic and Giant Cell Myocarditis: Uncovering Etiological Mechanisms.Front Cardiovasc Med2021https://conductscience.org/library/papers/34434981PubMed
34209535Neuroinflammation: A Signature or a Cause of Epilepsy?Int J Mol Sci2021https://conductscience.org/library/papers/34209535PubMed
34140850Increasing immunoglobulin G adsorption in dextran-grafted protein A gels.Eng Life Sci2021https://conductscience.org/library/papers/34140850PubMed
33795852The evolution of commercial drug delivery technologies.Nat Biomed Eng2021https://conductscience.org/library/papers/33795852PubMed
33534791Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial.PLoS Med2021https://conductscience.org/library/papers/33534791PubMed
33126648QSAR Implementation for HIC Retention Time Prediction of mAbs Using Fab Structure: A Comparison between Structural Representations.Int J Mol Sci2020https://conductscience.org/library/papers/33126648PubMed
32665404Structural features of bovine colostral immunoglobulin that confer proteolytic stability in a simulated intestinal fluid.J Biol Chem2020https://conductscience.org/library/papers/32665404PubMed

See all 142 cited byDownload CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22531442

GET https://conductscience.org/api/papers/v1/22531442/cited_by?page=2